New strategies in the treatment of cutaneous lymphoma;Aktuelle Behandlungsstrategien kutaner Lymphome

H+G Zeitschrift fur Hautkrankheiten

Volumn 72, Issue 4, 1997, Pages 257-262

  Stadler, R ^a   Otte, H G ^a  

^a KLINIKUM MINDEN   (Germany)

Author keywords

cutaneous T cell lymphoma; interferon; photopheresis; retinoid; treatment

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID ETHYL ESTER; ALPHA INTERFERON; ALPHA2A INTERFERON; ETRETINATE; INTERFERON; ISOTRETINOIN; METHOXSALEN; RETINOID;

CLINICAL ARTICLE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MYCOSIS FUNGOIDES; PHOTOCHEMOTHERAPY; PUVA; REVIEW; SEZARY SYNDROME; SKIN LYMPHOMA; SUBCUTANEOUS DRUG ADMINISTRATION; T CELL LYMPHOMA;

EID: 0030994092     PISSN: 03010481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Altomate GF, Capella GL, Pigatto PD, Finzi AF (1993) Intramuscular low dose alpha-2B interferon and etretinate for treatment of mycosis fungoides. Int J Dermatol 32:138-141
2. Bohmeyer J, Otte H-G, Stadler R (1996) Therapie des Sézary-Syndroms durch extracorporale Photochemotherapie. Hautarzt 47: 24-28
3. Braathen LR (1987) Interferon alfa 2a combined with etretinate: effective in the treatment of mycosis fungoides. Retinoids Today and Tomorrow 9: 17-19
4. Bunn PA jr, Foon KA, Ihde DC, Longo DL, Eddy J, Winkler CF et al. (1984) Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med 101: 484-487
5. Bunn PA jr, Hoffmann SJ, Noms D, Golitz LE, Aeling JL (1994) Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome). Ann Intern Med 121: 592-602
6. Claudy AL, Rouchouse B, Boucheron S, LePetit JC (1983) Treatment of cutaneous lymphoma with etretinate. Br J Dermatol 109: 49-56
7. Dallot A, Feyeux C, Carlotti A, Rybojad M, Gorin I, Verola O (1988) Low dose recombinant alpha 2B interferon in the treatment of cutaneous T-cell lymphomas [Abstract]. In: International Symposium on Cutaneous Lymphoma. Copenhagen, Denmark, pp 28-30
8. Dreno B, Celerier P, Litoux P (1993) Roferon-A in combination with tigason in cutaneous T-cell lymphomas Acta Haematol 89 (suppl 1): 28-32
9. Dreno B, Fleischman M, Valard S, Godefroy W, Bureau B, Stadler JF, Litoux P (1992) Die Induktion der Expression des myelomonozytären My7-Antigens in Basalzellen kutaner T-Zell-Lymphome durch Interferon alpha-2a. Br J Dermatol 126: 320-323
10. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B et al. (1987) Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 316: 297-303
11. Estrach T, Marti R, Lecha M, Mascaro JM (1989) Treatment of cutaneous T-cell lymphoma with recombinant alfa 2B interferon [Abstract]. J Invest Dermatol 93: 549
12. Hagberg H, Juhlin L, Scheynius A. Tjemlund V (1988) Low dose alpha interferon treatment in patients with advanced cutaneous T-cell lymphoma. Eur J Hematol 40: 31-34
13. Heald PW (1991) Photopheresis for cutaneous T-cell lymphoma. Ann N Y Acad Sci 636: 171-177
14. Honigsmann H, Brenner W, Rauschmeier W et al. (1984) Photochemotherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 10: 238-245
15. Noting E, Meissner K (1988) Arotinoid-ethylester: effectiveness in refractory cutaneous T-cell lymphoma. Cancer 62: 1044-1048
16. Kessler JF, Jones SE, Levine N, Lynch PJ, Booth AR (1987) Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides). Arch Dermatol 123: 201-204
17. Knobler R (1993) Interferon-alpha beim kutanen T-Zell-Lymphom. Wien Med Wochenschr 143: 435-437
18. Knobler RM, Trautlinger F, Radaszkiewicz T, Kokoschka EM, Micksche M (1991) Treatment of cutaneous T-cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids. J Am Acad Dermatol 24 (2 Pt.1): 247-252
19. Kohn EC, Steis R, Sansville E et al. (1990) Phase II trial of intermittant high dose recombinant interferon alfa 2a in mycosis fungoides and Sézary syndrome. J Clin Oncol 8: 155-160
20. Kuzel TM, Gilyon K, Springer E et al. (1990) Interferon alfa 2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst 82: 203-207
21. Kuzel TM, Roenigk HH jr, Samuelson E, Herrmann JJ, Hurria A, Rademaker AW, Rosen ST (1995) Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome. J Clin Oncol 13: 257-263
22. Lang MH, Altmeyer P, Lodemann E, Holzmann H (1986) Alpha-Interferon in der Therapie kutaner T-Zell-Lymphome. Z Hautkr 61:599-608
23. Molin L, Thomsen K, Volden G, Aronsson H, Hammar H, Hellbe L et al. (1987) Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. Acta Dermatol Venereol 67: 232-236
24. Nicolas JF, Bablanc JC, Frappaz A, Chouvet B, Delcombel M, Thivolet J (1989) Treatment of cutaneous T-cell lymphoma with intermediate doses of interferon alpha 2a. Dermatologica 179: 34-37
25. Olsen EA, Rosen ST, Vollmer RT, Variakojis D, Roenigk HH jr, Diab N et al: (1989) Interferon alfa-2a in the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 20: 395-407
26. Otte H-G, Herges A, Stadler R (1992) Kombinationstherapie mrt Interferon alfa 2a und PUVA bei kutanen T-Zell-Lymphomen. Hautarzt 43: 695-699
27. Papa G, Tura S, Mandelli F, Vegne M, Defazio D, Mazza P et al. (1991) Is interferon alpha in cutaneous T-cell lymphoma a treatment of choice? Br J Haematol 79 (suppl 1): 48-51
28. Rappersberger K, Ortel B, Forstinger C, Wolff K (1994) Therapie kutaner T-Zell-Lymphome. Wien Klin Wochenschr 106 (10) 300-308
29. Roenigk HH (1979) Photochemotherapy for mycosis fungoides: long term follow-up study Cancer Treat Rep 63F: 669-673
30. Sterry W (1988) Diagnostik der kutanen malignen Lymphome. Dtsch Med Wochenschr 113: 184-189
31. Sterry W (1988) Therapie der kutanen malignen Lymphome. Dtsch Med Wochenschr 113: 221-223
32. Stravnaneas N, Katsambas A. Vareltzides A, Stavropoulos P, Polydorou D, Zika P et al. (1989) Treatment of mycosis fungoides with recombinant alpha 2B interferon in combination with etretinate [Abstract]. J Invest Dermatol 93: 580
33. Thestrup-Pedersen K, Hammer R, Kaltoft K, Sogaard H, Zachariae H (1988) Treatment of mycosis fungoides with recombinant interferon-alpha 2a alone and in combination with etretinate. Br J Dermatol 118: 811-818
34. Thomsen K, Hammer H, Molin L, Volder G (1989) Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group. Acta Derm Venereol 69: 536-538
35. Thomsen K, Molin L, Volden G, Lange Wantzin G, Hellbe L (1984) 13-cis-retinoic acid effective in mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Group. Acta Derm Venereol 64: 563-566
36. Tura S, Mazza P, Zinzani PL, Ghetti PL, Poletti G, Gherilinzoni F et al. (1987) Alpha recombinant interferon in the treamtent of mycosis fungoides (MF). Hematologica 72: 337-340
37. Vegna ML, Papa G, Defazio D, Pisani F, Coppola G, DePita O et al. (1990) Interferon alpha-2a in cutaneous T-cell lymphoma. Eur J Haematol 52 (suppl 1):32-35
38. Vonderheid EC, Thompson R, Smiles KA, Lattandand A (1987) Recombinant interferon alfa-2b in plaque-phase mycosis fungoides: intralesional and low-dose intramuscular therapy. Arch Dermatol 123: 757-763
39. Zachariae H, Thestrup-Pedersen K (1990) Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma. J Invest Dermatol 95: 206S-208S